PRVA — Privia Health Income Statement
0.000.00%
Last trade - 00:00- $2.17bn
- $1.82bn
- $1.66bn
- 80
- 34
- 24
- 43
Annual income statement for Privia Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 786 | 817 | 966 | 1,357 | 1,658 |
| Cost of Revenue | |||||
| Gross Profit | 68.5 | 82.6 | 63.7 | 135 | 162 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 770 | 792 | 1,184 | 1,376 | 1,637 |
| Operating Profit | 16.1 | 25.4 | -217 | -19.1 | 20.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 9.15 | 23.5 | -219 | -18.6 | 29 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 7.95 | 30.9 | -191 | -12.1 | 21 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 8.24 | 31.2 | -188 | -8.59 | 23.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 8.24 | 31.2 | -188 | -8.59 | 23.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.08 | 0.304 | -1.81 | -0.03 | 0.231 |
| Dividends per Share |